<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>From Tokens to Blocks: A Block-Diffusion Perspective on Molecular Generation - Health AI Hub</title>
    <meta name="description" content="This paper introduces SoftMol, a novel unified framework designed to overcome limitations in existing GPT-based molecular language models (MLMs) for *de novo* m">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>From Tokens to Blocks: A Block-Diffusion Perspective on Molecular Generation</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2601.21964v1" target="_blank">2601.21964v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2026-01-29
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Qianwei Yang, Dong Xu, Zhangfan Yang, Sisi Yuan, Zexuan Zhu, Jianqiang Li, Junkai Ji
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.LG
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2601.21964v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2601.21964v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces SoftMol, a novel unified framework designed to overcome limitations in existing GPT-based molecular language models (MLMs) for *de novo* molecular design. SoftMol addresses the inadequate capture of graph-structured molecules and the lack of target-aware generation by proposing a block-diffusion model, SoftBD, using 'soft fragments' and a gated Monte Carlo tree search. The framework achieves superior chemical validity, improved binding affinity, higher molecular diversity, and significantly faster inference compared to state-of-the-art models.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>This research is highly relevant to drug discovery and development, as it provides a more powerful and efficient computational tool for generating novel drug-like molecules with specific desired properties, potentially accelerating the identification of new therapeutic candidates.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>AI-powered de novo drug design; generative AI for novel therapeutic compound identification and optimization; accelerating computational drug discovery processes.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>Identifies two fundamental limitations of current GPT-based MLMs: inadequate capture of molecular graph structure and lack of explicit target-aware generation mechanisms.</li>
                    
                    <li>Proposes SoftMol, a unified framework that co-designs molecular representation (soft fragments), model architecture (SoftBD), and search strategy (gated MCTS).</li>
                    
                    <li>Introduces 'soft fragments,' a rule-free block representation of SMILES strings, specifically designed to enable diffusion-native modeling of molecular structures.</li>
                    
                    <li>Develops SoftBD, the first block-diffusion molecular language model, which integrates local bidirectional diffusion with autoregressive generation while enforcing molecular structural constraints.</li>
                    
                    <li>Trains SoftBD on a carefully curated dataset, ZINC-Curated, to explicitly promote the generation of molecules with high drug-likeness and synthetic accessibility.</li>
                    
                    <li>Integrates a gated Monte Carlo tree search (MCTS) strategy within SoftMol to facilitate target-aware assembly of the generated 'soft fragments'.</li>
                    
                    <li>Demonstrates significant performance improvements over current state-of-the-art models, including 100% chemical validity, a 9.7% increase in binding affinity, 2-3x greater molecular diversity, and a 6.6x speedup in inference efficiency.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>SoftMol integrates three core components: 1) **Molecular Representation**: utilizes 'soft fragments,' a rule-free block representation of SMILES for diffusion-native modeling. 2) **Model Architecture**: introduces SoftBD, a block-diffusion molecular language model that combines local bidirectional diffusion with autoregressive generation under molecular structural constraints, trained on the ZINC-Curated dataset for drug-likeness and synthetic accessibility. 3) **Search Strategy**: employs a gated Monte Carlo tree search (MCTS) to enable target-aware assembly of the generated fragments.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>SoftMol achieved 100% chemical validity in generated molecules, improved binding affinity by 9.7% compared to state-of-the-art models, yielded a 2-3x increase in molecular diversity, and delivered a 6.6x speedup in inference efficiency.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>The enhanced capabilities of SoftMol in generating highly valid, diverse, and high-affinity molecules with improved computational efficiency can significantly expedite the initial stages of drug discovery, from hit identification to lead optimization. This could lead to a faster and more cost-effective pipeline for developing novel drugs, ultimately accelerating the availability of new treatments for various diseases.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state any limitations of the SoftMol framework itself. It primarily highlights its superior performance in overcoming the limitations of previous GPT-based MLMs.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The abstract does not explicitly mention future research directions.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">Drug discovery</span>
                    
                    <span class="tag">Medicinal chemistry</span>
                    
                    <span class="tag">Computational pharmacology</span>
                    
                    <span class="tag">Pharmaceutical research</span>
                    
                    <span class="tag">Biotechnology</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">molecular generation</span>
                    
                    <span class="tag tag-keyword">deep generative models</span>
                    
                    <span class="tag tag-keyword">molecular language models</span>
                    
                    <span class="tag tag-keyword">block-diffusion</span>
                    
                    <span class="tag tag-keyword">drug discovery</span>
                    
                    <span class="tag tag-keyword">de novo design</span>
                    
                    <span class="tag tag-keyword">SMILES</span>
                    
                    <span class="tag tag-keyword">target-aware generation</span>
                    
                    <span class="tag tag-keyword">Monte Carlo tree search</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">Drug discovery can be viewed as a combinatorial search over an immense chemical space, motivating the development of deep generative models for de novo molecular design. Among these, GPT-based molecular language models (MLM) have shown strong molecular design performance by learning chemical syntax and semantics from large-scale data. However, existing MLMs face two fundamental limitations: they inadequately capture the graph-structured nature of molecules when formulated as next-token prediction problems, and they typically lack explicit mechanisms for target-aware generation. Here, we propose SoftMol, a unified framework that co-designs molecular representation, model architecture, and search strategy for target-aware molecular generation. SoftMol introduces soft fragments, a rule-free block representation of SMILES that enables diffusion-native modeling, and develops SoftBD, the first block-diffusion molecular language model that combines local bidirectional diffusion with autoregressive generation under molecular structural constraints. To favor generated molecules with high drug-likeness and synthetic accessibility, SoftBD is trained on a carefully curated dataset named ZINC-Curated. SoftMol further integrates a gated Monte Carlo tree search to assemble fragments in a target-aware manner. Experimental results show that, compared with current state-of-the-art models, SoftMol achieves 100% chemical validity, improves binding affinity by 9.7%, yields a 2-3x increase in molecular diversity, and delivers a 6.6x speedup in inference efficiency. Code is available at https://github.com/szu-aicourse/softmol</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>30 pages, 13 figures, 11 tables</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>